Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Otsuka Holdings Co ( (JP:4578) ) is now available.
Otsuka Holdings Co., Ltd. reported a significant increase in revenue and profits for the first quarter of 2025, with revenue rising by 12.2% and operating profit by 35.2% compared to the same period in the previous year. Despite the positive financial performance, the company’s total comprehensive income saw a sharp decline of 96.9%. The company also announced the acquisition of Araris Biotech AG, indicating a strategic move to expand its scope of operations.
More about Otsuka Holdings Co
Otsuka Holdings Co., Ltd. is a company listed on the Tokyo Stock Exchange, primarily operating in the pharmaceutical and nutraceutical industries. The company focuses on developing innovative products and solutions in healthcare, with a strong emphasis on research and development to address unmet medical needs.
YTD Price Performance: -11.30%
Average Trading Volume: 148
Technical Sentiment Signal: Sell
Current Market Cap: $25.56B
Learn more about 4578 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue